1 14 10 Webinar Ox BioregMed

January 2010
Introduction to Homotoxicology and Bioregulatory Medicine
Introduction to Homotoxicology gy and Bioregulatory Medicine

Kristy Anderson, NMD
Medical Advisor - Bioregulatory Medicine g y

Kristy Anderson is a licensed Naturopathic Medical Doctor in the state of Arizona and is currently the Medical Advisor Bioregulatory Medicine for Heel USA serving at a national and international level for Heel with medical education and medical literature d lit t development. Sh i a published author on l t She is bli h d th Homotoxicology in the international journal, Journal of Biomedical Therapy and the journal Explore as well as lecturing nationally and internationally on Bioregulatory medicine. Dr. Anderson completed NIH grant-funded research on alternative oncology treatments while in medical school and believes in focusing on combining the best of western medicine and naturopathic medicine for the benefit of the patient. She is a graduate of the Southwest College of Naturopathic Medicine d t f th S th t C ll fN t thi M di i and an active member of the American Association of Naturopathic Physicians (AANP), the American College for Advancement of Medicine (ACAM).
January 2010
Complementary & Alternative or Integrative Medicine European countries use the term, g Biological Medicine Art and Science ! Therapeutic measures geared toward unique life stresses Healing methods are designed around an i di id l ability to d individuals bili regulate, regenerate, adapt and selfheal
3
Heel Inc. Worldwide

Largest combination homeopathic manufacturer worldwide
USA Chile Poland Brazil
Germany Columbia Belgium Spain
Canada SouthAfrica Sweden theNetherlands

4
January 2010
Definition of Homeopathy
A system of medicine utilizing medications manufactured according to homeopathic principles/standards Remedies stimulate the bodys own regulation and defense systems HOMEOPATHY = similar suffering ALLOPATHY = opposite suffering (a term coined by Hahnemann)
5
Homeopathy, Herbs and Dietary Supplements

HERBS: regulated as foods
May or may not be dietary supplements
DIETARY SUPPLEMENTS: regulated as foods HOMEOPATHICS: regulated as drugs g g
January 2010
FDA Regulations for Homeopathic Substances

Must be manufactured according to GMPs Must meet labeling standards for OTC and Rx products Must register establishment and drugs with Drug Listing Branch Must meet HPUS standards
Prescription (Rx) vs Over-the-Counter (OTC)

PRESCRIPTION For serious health disorders (labeling) Dosage form (injectables) Administration requires supervision OTC For self-limiting g conditions Self-diagnosed Self-treatable
January 2010
Principles of Homeopathy
The Law of Similars Testing of remedies on healthy g y individuals called provers Prescribing based on the totality of symptoms The use of the minimum dose Potentization of the remedy
Potency - Strength of the ingredient

Diluent is alcohol, glycerin or lactose Decimal designated with an X and centesimal scale is a C C Heel and BHI formulas are ALL in the decimal scale
10
January 2010
Process of Potentization
Potentization involves the serial dilution and succussion (vigorous shaking) of the substance during preparation. Hahnemann discovered that the process of potentization increased the healing power of the remedy while reducing its toxic side effects Example: metals or charcoal
Potentization renders the product nontoxic
11
High vs. Low Potencies

Dilution influences the effect the substance has on the patient
L Low dil ti dilutions affect physical symptoms ff t h i l t High dilutions (200x and above) can affect mental/emotional symptoms
Heel Homaccord preparations are the only products that have higher potency levels (200x, 1000x)
All homaccords are in liquid or oral vial dosage form
12
January 2010
Limitations in Classical Homeopathy

Detailed case-taking and extensive familiarity with the existing materia medica is required Todays chronic diseases may be related to environmental toxins, side effects of vaccines, and symptom-suppressing allopathic medicines Todays patients are highly toxic!!
13
Hans Heinrich Reckeweg, MD

Founder of Heel
Conventionally trained as MD in Bonn, Germany (graduated in 1929), continued with classical homeopathic training in Berlin Witnessed father cured of degenerative kidney disease with homeopathy Developed the principles of homotoxicology in 1952; moved to Baden-Baden in 1955
14
January 2010
The Roots of Homotoxicology

Reckeweg was trained as a classical homeopath, and applied those principles in the early days of his practice as an MD in Germany He did not have the clinical success he had hoped for with the application of single remedies
15
Experimental Phase
Reckeweg experimented with combining ingredients AND utilizing unusual ingredients- which was a departure from classical homeopathy However, he saw positive changes in his patients reacting to these medicines
16
January 2010
Reckewegs Vision
Eventually, Reckeweg formed a company/product line around this vision To create a bridge between classical homeopathy and conventional medicine with homotoxicology.
17
Integration
Allopathy
Homeopathy
Homotoxicology presents a simplified logical simplified, and technically-based method of using homeopathic principles in daily practice
18
January 2010
Complementary / Integrative Perspective

Dr. Reckewegs methodology allows practitioners to combine conventional training with basic concepts of homeopathy.
Practitioners Handbook of Homotoxicology
19
Homotoxicology
Human Toxin Study (poison to humans) The study of the influence of toxins on the human organism Reckeweg viewed diseases as a biologically purposeful process g yp p p
manifestation of the bodys defense system
20
10
January 2010
Homotoxicology
Essential tenet:
According to Homotoxicology, all those processes, processes syndromes and manifestations which we designate as diseases are the expression thereof that the body is combating poisons and that is wants to neutralize and excrete these poisons. The body either wins or loses the fight thereby. Those processes which we designate as diseases are always biological biological, that is, natural teleological processes which serve poison defense and detoxification.
21
Homotoxicosis
Non-physiological condition which arises after the reaction of a homotoxin on cells or tissues in the body
22
11
January 2010
Struggle Against Toxins

From a homotoxicological perspective, illnesses are seen as the struggles against endogenous and exogenous toxins to bring the body back to homeostasis Illnesses may represent the attempt of the body to compensate for damages caused by toxins b t i
23
What Happens With Toxic Exposure?

Body encounters a homotoxin Initiates series of reactions to either eliminate the toxin or control its biological effects Reckeweg identified and classified the various reactions that the body can mount against h i t homotoxins t i
24
12
January 2010
Toxins
Endogenous lactic acid, histamine, antigen-antibody complexes Exogenous- air pollution, toxins in food (preservatives, chemicals, etc), bacteria, viruses Pork toxins- pig viruses, similarity of tissue Allopathic drug residue or impact
25
Living Organisms as Flow Systems

Substances flow into the organism, take part in a variety of reactions, and then leave Substances conducive to health support the flow system without disturbing equilibrium
T i substances t i Toxic b t trigger d f defensive i reactions which upset flow system equilibrium
26
13
January 2010
PRINCIPLES OF ACTION OF BIOLOGICAL MEDICINE

27
Bioregulatory Medicine
Therapeutic modality within integrative medicine. M di l di Medical diagnosis i made, with an i is d ith individualized assessment Patients self-regulatory mechanisms are considered Treatment aim is to support the inherent self-regulatory self regulatory ability
Detoxification and drainage Immunomodulation Functional organ and cellular support
28
14
January 2010
Pharmacotherapy
Components within the combination formulas activate the immune/defense system Immunological bystander reaction for use in inflammatory disorders
Brings about immunomodulation
Based on the principle that low doses stimulate and large doses inhibit
Science of Hormesis (Ardnt-Schultz Law) 1X 14X range
4X to 8X are most favorable
29
Pharmacotherapy Higher potencies (14X +), trace elements and intermediary catalysts stimulate the matrix, but do not necessarily induce immunomodulation Potentization of the ingredient plays a significant role in its ability to regulate and activate systems in the body
30
15
January 2010
Immunological Bystander Reaction Induction of cells by non-toxic antigen (homeopathic remedy) Exert effect on the processes of inflammation which were started by another antigen somewhere else in the body
MODULATION
31
Immunological Bystander Reaction

Formulas which have the ability to immunomodulate
Immunomodulate stimulate a weak immune system, yet calm a hyperactive system
Immunomodulation depends on the ingredients contained

Amino acid sequence
Plant extracts, suis organ extracts nosodes & animal extracts extracts, venoms
Dilution from 1X-14X
32
16
January 2010
Th3 as a Fulcrum
33
BIOREGULATORY MEDICINE AND THE DISEASE EVOLUTION TABLE (DET)

34
17
January 2010
Why is the DET such a good tool?

Can establish the prognosis of the patient Planning and adjusting the therapy Following the health g progression during treatment
35
36
18
January 2010
37
Decision Tree
How to locate a patient on the Disease Evolution Table What is the evolution What are the consequences for the treatment plan
38
19
January 2010
Decision Tree
Features
Phase characteristics
Therapy
39
Decision Tree
Chromosomaldamage, atypicalcells, frankmalignancy Malignancypresent Premalignancypresent Yes: Treatment PPG,MPG; PPG, MPG; CPG,ORPG
NO
Tissuedestruction
Degenerationpresent
Yes: Treatment PPG,MPG; CPG,ORPG
NO Enzymedamage, functionaldamage, exacerbationswith periodsofnormality
Functionaldisturbance on atissuelevel
Yes: Treatment PPG,MPG; CPG,ORPG

40
20
January 2010
Decision Tree
Tissuesaggregatedin abnormalbenigngrowths orsubstanceshave aggregatedinto deposition Depositionpresent Yes: Treatment PPG,MPG
NO
Inflammatoryprocess aonceoffprocess
Acuteinflammationpresent
Yes: Treatment PPG,MPG
NO Increasedsecretion ofanormalphysiological processinview ofahomotoxin Yes: Treatment PPG,MPG

41
Increasedexcretion offluids, neurotransmitters
Classification of the patient on the DET

Lymphoma
Organ System/Tissue - Mesoderm mal Dedifferentiation
Lymphoma
42
21
January 2010
The importance of the horizontal axis

Gives an idea of how well the patient regulates with a toxin load, and reflects the most upto-date status of the patient Allows us to follow the stages the patient has gone through in their history of treatment Treatment is always planned according to the phase which is the furthest on the right
43
The importance of the vertical axis

Gives an indication of the tissue most affected in the patient This may be genetically predisposed This may be the organ / organ system with the least resistance or weak spot in the body The embryological layers make it possible to treat different layers in the same organ and also follow disease in the same organ
44
22
January 2010
DESIGNING TREATMENT WITH THE THREE PILLARS ON THE DET
Development of Disease
46
23
January 2010
The Journey
The disease process of a patient is a journey for the practitioner For a journey you need
A Map Knowledge of the terrain you are going to cross Selection of the appropriate vehicle Selection of the appropriate fuel
47
Planning treatment in Bioregulatory Medicine

The Map The Disease Evolution Table The Territory The Greater Defense System The Vehicle The Three Pillars The Fuel The Medications
According to the pharmacological groups (plants, minerals, catalysts, etc.) According to the composition (basic, compositum, homaccord, etc.)
48
24
January 2010
The Autoregulatory System
THE TERRITORY
The Autoregulatory System

The Immune System The Nervous System Cellular Respiration The Neural Reflexes The Liver The Mucosal Surfaces
The Hypothalamic pituitary hormonal axis
50
25
January 2010
Regulatory systems
Three characteristics:
Interaction Feedback Oscillation and rhythm
Restore all three and observe all three
51
Regulatory systems
52
26
January 2010
Regulatory systems
53
The Three Pillars of Homotoxicology
THE VEHICLE
27
January 2010
THREE PILLARS OF HOMOTOXICOLOGY
Three Pillars
DETOXIFICATION AND DRAINAGE
IMMUNOMODULATION
ORGAN REGULATION AND CELLULAR ACTIVATION
56
28
January 2010
DETOXIFICATION AND DRAINAGE
Detoxification and Drainage
Functional support and F ti l t d drainage
Organ support of the O t f th detoxification and elimination organs
58
29
January 2010
Detoxification and Drainage: Basic & Advanced
59
Possible with amino acids: plants, suis organs, venoms, nosodes
IMMUNOMODULATION
30
January 2010
Immunomodulation
Basic functional B i f ti l
With organ support t
61
TH0 TH3 TH1 TH2
IL-2 IFN gamma TNF
IL-4, 13
TGF-beta
IL-5 IL-10 IL 10
To down regulate use Traumeel, Echinacea compositum
To down regulate use Engystol, Tonsilla compositum
62
31
January 2010
ORGAN STRENGTHENING
Organ Strengthening & Cellular Activation
Functiotropic
Organotropic
64
32
January 2010
Organ Strengthening & Cellular Activation
Cellular energy activation
Basic
Advanced
65
The Antihomotoxic Homeopathic Medication
THE FUEL
33
January 2010
Classification of medications by ingredients

Pharmacological groups (PGs):
Plants, PPG Minerals, MPG Catalysts, CPG Organ regulator pharmacological group, ORPG
This includes organ preparations (organ regulator and immunomodulator) Venoms (immunomodulator) Nosodes (deep immunomodulator)
67
Classification of medication by composition

By composition (type):
Special Heel preparations Homaccords Composita Catalysts
68
34
January 2010
Treatment plan on the DET
Detoxification D t ifi ti Cellular ti ti C ll l activation and Drainage basic immunomodulation
Organ regulation O l ti and advanced immuno-modulation
PLANTS MINERALS
CATALYSTS
NOSODES VENOMS SARCODES
Basic combinations Homaccords Catalysts Composita
69
Steps in planning treatment

1. Classify the patient on the DET pp p pillar for the 2. Choose the appropriate p disease 3. Choose the appropriate medication 4. Check the appropriateness of the prescription
70
35
January 2010
Flow chart
Classify on DET
Choose pillar
Choose medication
Counter check prescription

71
Treatment with the Three Pillars

Indication based
Symptomatic
Basic preparation Homaccord
Support regulation
Detoxification and Drainage

Three pillars
Immunomodulation
Organ strengthening and cellular activation
72
36
January 2010
Example 1: Patient with increased sweating and body odor

Excretion Orga System/Tissue - Ec an ctodermal
Classify on DET Choose the appropriate pillar Drainage, thus

Basic preparation: Schwef-Heel Drainage: Detox-Kit
Check medication for appropriateness:

PPG, MPG Special Heel combination
73
Example 2: Patient with recurrent boils

Org System/Tissue - Ectodermal gan E
Inflammation
Classify on DET Choose the appropriate pillar

Basic treatment: Belladonna-Homaccord Basic immunomodulation: Traumeel Basic Detox and Drainage: Detox-Kit for 6 weeks

PPG, MPG Special Heel combination Homaccord
74
37
January 2010
Example 3: Patient with kidney stones

Deposition
Organ System/Tissue - Mes sodermal

Basic preparation: Reneel (Rx) Drainage: Detox-Kit for 12 weeks, add Organ support: Berberis-Homaccord, Coenzyme compositum (functional and catalysts)

PPG, MPG, CPG Special Heel combination Homaccord Catalyst
75
Example 4: Patient with Idiopathic Thrombocytopaenic Purpura (ITP)

Impregnation
Orga System/Tissue - Me an esodermal

Basic preparation: Tonsilla compositum or Thyreoidea compositum (Rx) Detox & Drain: Advanced support 6 weeks and then Detox-Kit 12 weeks weeks, Organ support: Tonsilla compositum (immune regulation and organ support) Coenzyme compositum plus Ubichinon compositum

PPG, MPG, CPG, ORPG Basic combination, Homaccords, Composita, Catalyst
76
38
January 2010
Example 5: Patient with Chronic Obstructive Airway Disease

Degeneration
Organ System/Tissue - Mes sodermal

Basic preparation: Bronchalis-Heel, Tartephedreel Detox & Drain: Organ support 6 weeks and then Detox-Kit 12 weeks Immune regulation and organ support : Mucosa compositum Cellular activation: Coenzyme compositum plus Ubichinon compositum Check medication for appropriateness: PPG, MPG, CPG, ORPG Basic Heel combination, Homaccord, Composita, Catalyst
77
Example 6: Patient with Breast Cancer

Organ System/Tissue - End n dodermal
Dedifferent -iation

Basic preparation: Arsuraneel Detox & Drain: Organ support 6 weeks and then Detox-Kit 12 weeks (start D&D 6 weeks after chemo NOT during) Immune regulation: Viscum compositum Forte Organ support: Ovarium compositum Catalyst: Glyoxal compositum followed by Coenzyme compositum and Ubichinon compositum

PPG, MPG, CPG, ORPG Basic Heel combination, Homaccord, Composita, Catalyst, Injection solution
78
39
January 2010
How do I apply the Three Pillars?

Designed to induce regulation & stimulate patients ability to regulate Applied in cycles, with time for assessment in between pp y , When patient starts to regulate, the pillars may be adjusted or continued, depending on how long the patient stays to the left of the regulation division It often takes a few attempts of the body to mount a regulation response which will last Regulation needs to continue until at least three of four episodes of self regulation are observed (see next slide) The basic, symptomatic medication is often given for longer periods
79
Regulation phenomena
The following events show that the patient is moving to the left of where they currently are on the DET:
Acute infections and inflammations classified in the inflammation phase Deposition phenomena getting worse in p patients who p present in the impregnation p g phase
80
40
January 2010
Treatment of conditions to the left of the Regulation Division

Humoral Phases
Excretion Phase Inflammation Phase
Matrix Phases
Deposition Phase Impregnation Phase
Cellular Phases
Degeneration Phase Dedifferentiatio n Phase
Ectodermal
Endodermal
Pillar or pillars are applied for a shorter time, until a shift is seen. In phase 1 and 2 often 6 weeks is g phase 3 may need y enough, in p several cycles
Mesenchymal
Mesodermal
Tissue
Regulation/Compensation Division
81
The importance of the Regulation/Compensation Division

Humoral Phases
Excretion Phase Inflammation Phase
Matrix Phases
Deposition Phase Impregnation Phase
Cellular Phases
Degeneration Phase Dedifferentiatio n Phase
Ectodermal
Endodermal
Mesenchymal
Three pillars are applied in cycles, of mostly three months with a rest period in between of 6 weeks, until a shift is seen in the DET to the left (see above)
Mesodermal
Tissue
Regulation/Compensation Division
82
41
January 2010
Summary
Use the DET as a map
Use indications on it as references
Always remember the Decision Tree The Three Pillars

Not always used, but must be considered
Know the medications Watch & listen to your patient
83
Lets Recap
84
42
January 2010
Who can use Heel products & what modalities can be used with them?
Who can use Heel products? MD ND DC LAc/DOM PA DPM DO PhD PharmD DDS What kind of skills/training? py Sauna Therapy Homotoxicology Manipulation Therapy Chi Kung Hypnosis
Herbal/Phyto Therapy Acupuncture Anthroposophical p p Therapy Homeopathy Meditation
RN
MT
Others
85
TOOLS OF THE TRADE

Practitioners Handbook STUDIES!!!
Our products have been researched for many years and there are copies of these articles available to you just ask your Sales Rep
EDUCATIONAL EVENTS
University Seminars, Roundtables, Expos and Teleconferences
86
43
January 2010
Diagnosis!
In order to correctly select a product for patient treatment
YOU MUST FIRST HAVE A DIAGNOSIS OR INDICATION!!

87
Lets Recap
Homotoxicological medicines have virtually no side effects or contraindications No known or reported drug interaction or reactions In many cases, they are safe for infants and elderly people!
88
44
January 2010
Thank you!
89
45

1 14 10 Webinar Ox BioregMed

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1 14 10 Webinar Ox BioregMed

Uploaded by

Copyright:

Available Formats

January 2010

Introduction to Homotoxicology and Bioregulatory Medicine

Introduction to Homotoxicology gy and Bioregulatory Medicine

Kristy Anderson, NMD

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Heel Inc. Worldwide

USA Chile Poland Brazil

Germany Columbia Belgium Spain

Canada SouthAfrica Sweden theNetherlands

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Homeopathy, Herbs and Dietary Supplements

DIETARY SUPPLEMENTS: regulated as foods HOMEOPATHICS: regulated as drugs g g

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

FDA Regulations for Homeopathic Substances

Prescription (Rx) vs Over-the-Counter (OTC)

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Potency - Strength of the ingredient

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

High vs. Low Potencies

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Limitations in Classical Homeopathy

Hans Heinrich Reckeweg, MD

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

The Roots of Homotoxicology

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Complementary / Integrative Perspective

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Struggle Against Toxins

What Happens With Toxic Exposure?

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Living Organisms as Flow Systems

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

PRINCIPLES OF ACTION OF BIOLOGICAL MEDICINE

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Immunological Bystander Reaction

Immunomodulation depends on the ingredients contained

Dilution from 1X-14X

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

BIOREGULATORY MEDICINE AND THE DISEASE EVOLUTION TABLE (DET)

Kristy Anderson, NMD

Introduction to Homotoxicology and Bioregulatory Medicine

Why is the DET such a good tool?

Kristy Anderson, NMD